Venous thromboembolism in southern Chinese patients with systemic lupus erythematosus
- PMID: 20101427
- DOI: 10.1007/s10067-009-1364-z
Venous thromboembolism in southern Chinese patients with systemic lupus erythematosus
Abstract
The objective is to study the annual incidence and standardized incidence ratio (SIR) of venous thromboembolism (VTE) in a cohort of Chinese patients with systemic lupus erythematosus (SLE). VTE events of SLE patients occurring between 1999 and 2008 were identified from our database, and the annual incidence of VTE was calculated according to the cohort size. SIRs were estimated by the ratios of the incidence of VTE in SLE to the general population. In 2008, 516 SLE patients were in our cohort. The mean age of SLE onset was 32.2 +/- 14 years and the duration of SLE was 9.3 +/- 8.8 years. Fifty-seven percent of the patients had disease duration of > or =5 years. Between 1999 and 2008, 18 episodes of VTE occurred in 14 patients. The incidence of VTE did not show significant fluctuation and the mean annual incidence was 4.2/1,000 patient-year. The reported VTE events were: popliteal vein thrombosis (56%), pulmonary embolism (22%), renal vein, retinal vein, subclavian vein and dural sinus thrombosis (5.6% each). The cumulative risks of VTE since SLE diagnosis were 2.8% and 3.7% at 5 and 10 years, respectively. Compared to the general population, the mean SIR of VTE in SLE patients within this period was 11.9 (7.31-19.6; p < 0.001). The SIR of VTE was highest in patients under the age of 30 years. The presence of the antiphospholipid antibody was independently associated with VTE (HR 4.36 [1.67-11.4]; p = 0.003). Although venous thrombosis is uncommon in Chinese, Chinese patients with SLE are 12 times more prone to VTE than the general population.
Similar articles
-
The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study.Semin Arthritis Rheum. 2015 Oct;45(2):195-201. doi: 10.1016/j.semarthrit.2015.05.008. Epub 2015 May 19. Semin Arthritis Rheum. 2015. PMID: 26364556 Free PMC article.
-
Long-term incidence, risk factors and complications for venous thromboembolism in patients with systemic lupus erythematosus.Lupus. 2024 Jul;33(8):787-796. doi: 10.1177/09612033241247359. Epub 2024 Apr 24. Lupus. 2024. PMID: 38655753 Free PMC article.
-
Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus.RMD Open. 2023 Nov 23;9(4):e003568. doi: 10.1136/rmdopen-2023-003568. RMD Open. 2023. PMID: 37996129 Free PMC article.
-
Systematic Literature Review and Meta-analysis of Venous Thromboembolism Events in Systemic Lupus Erythematosus.Rheumatol Ther. 2023 Feb;10(1):7-34. doi: 10.1007/s40744-022-00513-1. Epub 2022 Dec 6. Rheumatol Ther. 2023. PMID: 36471199 Free PMC article. Review.
-
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review.Autoimmun Rev. 2023 Nov;22(11):103447. doi: 10.1016/j.autrev.2023.103447. Epub 2023 Sep 14. Autoimmun Rev. 2023. PMID: 37714419 Review.
Cited by
-
The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study.Semin Arthritis Rheum. 2015 Oct;45(2):195-201. doi: 10.1016/j.semarthrit.2015.05.008. Epub 2015 May 19. Semin Arthritis Rheum. 2015. PMID: 26364556 Free PMC article.
-
Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians.Arthritis Rheum. 2013 Jan;65(1):211-5. doi: 10.1002/art.37751. Arthritis Rheum. 2013. PMID: 23124848 Free PMC article.
-
Systemic Lupus Erythematosus Is Associated With a High Risk of Venous Thromboembolism in Hospitalized Patients Leading to Poor Outcomes and a Higher Cost: Results From Nationwide Inpatient Sample Database 2003-2011.ACR Open Rheumatol. 2019 May 13;1(3):194-200. doi: 10.1002/acr2.1030. eCollection 2019 May. ACR Open Rheumatol. 2019. PMID: 31777795 Free PMC article.
-
Postoperative risk of venous thromboembolism in rheumatic disease patients.Curr Rheumatol Rep. 2015 Feb;17(2):11. doi: 10.1007/s11926-014-0488-6. Curr Rheumatol Rep. 2015. PMID: 25691333 Review.
-
Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.Thromb Res. 2015 Jan;135(1):50-7. doi: 10.1016/j.thromres.2014.10.012. Epub 2014 Oct 22. Thromb Res. 2015. PMID: 25456001 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical